Various laboratory diagnostic tests for Sexually Transmitted Diseases (STDs) include, chlamydia diagnostic tests that include, Direct Fluorescent Antibody (DFA), Enzyme immunoassay (EIA), molecular-based diagnostic testing / DNA probes, Nucleic Acid Amplification Tests (NAATs), Polymerase Chain Reaction (PCR), Ligase Chain Reaction (LCR), Transcription Mediated Amplification (TMA), and Strand Displacement Assay (SDA).
Statistics:
The global diagnostic testing of STDs market is estimated to account for US$ 290,128.2 Mn in terms of value by the end of 2027.
Global Diagnostic Testing of STDs Market: Drivers
Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. For instance, in November 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of Sentosa SQ HIV Genotyping Assay, a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology.
Note: *The Download PDF brochure only consists of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3917
Global Diagnostic Testing of STDs Market: Opportunities
Increase in STDs awareness is expected to offer lucrative growth opportunities for players in the global diagnostic testing of STDs market. For instance, in March 2020, researchers from Albaha University, Saudi Arabia, reported lack of STDs knowledge among young adults with estimated overall mean of STDs- knowledge scores of 7.95 ± 4.29.
Global Diagnostic Testing of STDs Market: Restraints
Large proportion of STD infected patients in out-of-reach geographic areas is expected to hinder growth of the market. It is observed that a large proportion STD infected patients and related / undetected cases are in out-of-reach geographic areas in many developing regions. The provision of infrastructure such as labs, equipment and supplies, trained laboratory experts or personnel proves uneconomic due to location constraints / deep difficult-to-reach areas. Lack of ease of accessibility and inadequate and unreliable infrastructure thus deters many from voluntary / Client-Initiated Counselling and Testing (CICT) diagnostic testing of STDs.
Key Takeaways:
The global diagnostic testing of STDs market was valued at US$ 140,028.5 Mn in 2019 and is forecast to reach a value of US$ 290,128.2 Mn by 2027 at a CAGR of 9.6% between 2020 and 2027. Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3917
Chlamydia segment held dominant position in the global diagnostic testing of STDs market in 2019, accounting for 29.9% share in terms of value. Increasing incidence and prevalence of chlamydia in developing economies is expected to drive the segment growth during the forecast period.
Market Trends
Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2019, bioLytical Laboratories launched the INSTI HIV-1 / HIV-2 Antibody Test in Canada.
North America is witnessing increasing adoption of STD testing. For instance, in May 2020, GoodRx, Inc. announced the GoodRx labs marketplace to offer 18 different tests by direct-to-consumer companies such as myLAB Box, Paloma Health and HeyDoctor by GoodRx for conditions such as allergies, coronavirus, diabetes, thyroid, cholesterol, urine analysis, STDs, fertility, and pregnancy.
Global Diagnostic Testing of STDs Market: Competitive Landscape
Major players operating in the global diagnostic testing of STDs market include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
Need a discount?
Note: *The discount is offered on the Standard Price of the report.
Request discount for this report @ https://www.coherentmarketinsights.com/insight/request-discount/3917
Global Diagnostic Testing of STDs Market: Key Developments
August 2019: binx health received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its binx io, a molecular point-of-care diagnostic testing platform for the detection of chlamydia and gonorrhea
May 2019: Hologic, Inc. received the U.S. FDA clearance for its Aptima BV and Aptima CV/TV assays used for diagnosing vaginitis
Segmentation
- Global Diagnostic Testing of STDs Market, By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- Global Diagnostic Testing of STDs Market, By Region:
- North America
- By Test Type:
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
- By Country
- U.S.
- Canada
- By Test Type:
- Latin America
- By Test Type:
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Test Type:
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Test Type:
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Test Type:
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Test Type:
- By Country
- North Africa
- Central Africa
- South Africa
- North America
- Company Profiles
- Vela Diagnostics USA Inc. *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Roche Holdings AG
- Alere, Inc.
- Becton Dickinson & Company
- bioMerieux
- Danaher Corporation (Beckman Coulter)
- Hologic, Inc.
- binx health
- Chembio Diagnostics
- Pinpoint Science Inc.
- bioLytical Laboratories.
- Vela Diagnostics USA Inc. *
Browse Press Release: https://www.coherentmarketinsights.com/press-release/diagnostic-testing-of-stds-market-3186
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837